Treatment Appears To Reduce Heart Attack Risk And Revascularisation In Stable Coronary Patients
Sunday, August 31, 2008 - 21:21
in Health & Medicine
Ivabradine is the first antianginal treatment shown to reduce myocardial infarction and revascularisation and to have a good tolerability profile even when used with other drugs.
Read the whole article on Science Daily
More from Science Daily
Related
- The BEAUTIFUL studyTue, 2 Sep 2008, 10:15:17 EDT
- Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromesMon, 31 Aug 2009, 10:30:26 EDT
- Blood pressure drug combination reduces heart attack deathsTue, 16 Sep 2008, 13:45:51 EDT
- Invasive treatment appears beneficial for men and high-risk women with certain coronary syndromesWed, 2 Jul 2008, 10:07:48 EDT
- New genomic markers associated with risk of heart disease and early heart attackWed, 18 Feb 2009, 10:37:23 EST